SGLT-2 Inhibition in Kidney Transplant Recipients With Diabetes – DocWire News
Previous studies have shown that the use of sodium glucose linked transporter inhibitors (SGLT-2i) in nontransplant patients with diabetes and chronic kidney disease (CKD) reduces cardiovascular mortality and delays progression…